IP Library Granted Patent US 12,539,384
Granted Patent B2
US 12,539,384 · App. 18/078,196 · Granted Feb 3, 2026

Patient interface

Inventors: Alicia Kristianne Wells (Sydney, AU); Craig David Edwards (Sydney, AU); Shiva Kumar Shanmuga Sundara (Sydney, AU); Murray William Lee (Sydney, AU); Kirrily Michele Haskard (Sydney, AU); Anthony Paul Barbara (Sydney, AU); Stewart Joseph Wagner (Hawkesbury, AU); Chia Ik Tan (Sydney, AU); Frederick Arlet May (Sydney, AU); Lachlan Richard Goldspink (Sydney, AU); Martin Forrester (Trenton, CA); Ralph Jourdan (Morfelden, DE)
Assignee: ResMed Pty Ltd
A61M16/0672A61M16/06A61M16/0622A61M16/0683A61M16/00A61M16/0633A61M16/0825A61M16/1055A61M16/107A61M2205/0216A61M2210/0618
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,539,384
App. No.
18/078,196
Granted
Feb 3, 2026
Kind
B2
Abstract

A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member.

Claims (103)

1 . A patient interface for providing a flow of air at a therapeutic pressure above ambient air pressure to a patient throughout the patient's respiratory cycle to treat sleep disordered breathing, the patient interface comprising:

a frame constructed from a first material, the frame having a connection port, and the frame having a first group of vent holes positioned on a first lateral side of the connection port and a second group of vent holes positioned on a second lateral side of the connection port that is opposite the first lateral side;

a seal-forming structure removably connected to the frame to at least partly form a gas chamber, the seal-forming structure being configured to contact and seal against the patient's face to deliver the flow of air to the patient's nares during use, the seal-forming structure being configured to leave the patient's mouth uncovered in use, and the seal-forming structure being constructed from a second material that is more flexible than the first material;

a tube connected to the frame at the connection port without an elbow and configured to direct the flow of air into the gas chamber for breathing by the patient;

a pair of rigidizer arms constructed from a third material that is more flexible than the first material and less flexible than the second material, each of the rigidizer arms being connected to the frame; and

a strap constructed from a textile material, the strap having a pair of length-adjustable side strap portions, each of the length-adjustable side strap portions being removably connected to a corresponding one of the rigidizer arms, the strap having a length-adjustable top strap portion positioned between and connected to each of the length-adjustable side strap portions, the strap having a back strap portion positioned between and connected to each of the length-adjustable side strap portions, and a gap being formed between the length-adjustable top strap portion and the back strap portion.

2 . The patient interface of claim 1 , wherein a pair of mesh portions are positioned on the frame on a corresponding lateral side of the connection port, and the first group of vent holes and the second group of vent holes being formed through corresponding ones of the mesh portions.

3 . The patient interface of claim 1 , wherein the tube is permanently connected to the frame at the connection port.

4 . The patient interface of claim 1 , wherein a cuff is overmolded onto the tube, and

wherein the cuff is joined to the frame at the connection port with an overmolded connection.

5 . The patient interface of claim 1 , wherein the first material and the third material are unable to be integrally bonded.

6 . The patient interface of claim 1 , wherein the seal-forming structure comprises nasal pillows configured to contact and seal against the underside of the patient's nose at corresponding ones of the patient's nares.

7 . The patient interface of claim 1 , wherein the seal-forming structure comprises a nasal cradle.

8 . The patient interface of claim 1 , wherein the seal-forming structure comprises a single orifice configured to direct the flow of air into both of the patient's nares during use.

9 . The patient interface of claim 1 , wherein the rigidizer arms are joined to the frame separately from one another.

10 . The patient interface of claim 1 , wherein the frame includes a channel portion and the seal-forming structure includes a tongue portion configured to be inserted into the channel portion when the seal-forming structure is removably connected to the frame.

11 . The patient interface of claim 1 , wherein the frame is symmetric across a first plane,

wherein each of the rigidizer arms comprises a first curve such that a first portion of each of the rigidizer arms extends away from the first plane at the first curve, and

wherein each of the rigidizer arms comprises a second portion that extends from the first portion, the second portion having a second curve such that a surface of the second portion that faces the first plane is concave and configured to be positioned against a corresponding one of the patient's cheeks in use.

12 . The patient interface of claim 11 , wherein the second portion of each of the rigidizer arms is upwardly curved such that in use a corresponding one of the length-adjustable side strap portions is directed between corresponding ones of the patient's eyes and ears.

13 . The patient interface of claim 1 , wherein the textile material is elastically stretchable.

14 . The patient interface of claim 1 , wherein the length-adjustable side strap portions are dimensioned such that the length-adjustable top strap portion and the back strap portion and the gap are positioned posterior to the patient's ears in use.

15 . The patient interface of claim 1 , wherein the length-adjustable side strap portions, the length-adjustable top strap portion, and the back strap portion are dimensioned such that the length-adjustable top strap portion and the back strap portion split from one another at a location superior to the patient's ears in use.

16 . The patient interface of claim 1 , wherein the length-adjustable top strap portion is configured to engage the patient's head across the parietal bones in use and the back strap portion is configured to engage the patient's head proximal to the occipital bone in use.

17 . The patient interface of claim 1 , wherein each of the rigidizer arms comprises an enclosable section, the frame being overmoulded around the enclosable section of each of the rigidizer arms.

18 . The patient interface of claim 1 , wherein the rigidizer arms and the frame are integrally bonded.

19 . The patient interface of claim 1 , wherein each of the rigidizer arms comprises a main body portion and an extension portion that extends from the main body portion and is joined to the frame, and

wherein the extension portion is narrower than the main body portion.

20 . The patient interface of claim 1 , wherein each of the length-adjustable side strap portions comprises a sleeve portion, each of the rigidizer arms extending into the sleeve portion of a corresponding one of the length-adjustable side strap portions.

21 . The patient interface of claim 1 , wherein the textile material is flexible such that a distance between the length-adjustable top strap portion and the back strap portion is adjustable in use.

22 . The patient interface of claim 1 , wherein the second material is silicone.

23 . The patient interface of claim 22 , wherein the seal-forming structure further comprises a base that is removably connected to the frame.

24 . The patient interface of claim 23 , wherein the base is constructed from silicone having a higher durometer than silicone of the remainder of the seal-forming structure.

25 . The patient interface of claim 24 , wherein the base and the frame are structured to be removably connected with an audible snap fit.

26 . The patient interface of claim 23 , wherein the frame includes a rim that extends away from the frame in a direction opposite the connection port, the rim forming an opening, and

wherein an inner periphery of the base is configured to surround and seal against an outer periphery of the rim when the base is removably connected to the frame.

27 . The patient interface of claim 1 , wherein each of the rigidizer arms is connected to a corresponding lateral side of the frame with an overmolded connection.

28 . The patient interface of claim 1 , wherein the tube comprises a swivel connector positioned on an end of the tube opposite the frame.

29 . The patient interface of claim 1 , wherein a visual indicator is formed on an exterior surface of the seal-forming structure to indicate orientation of the seal-forming structure for assembly to the frame.

30 . The patient interface of claim 1 , wherein:

the tube is permanently connected to the frame at the connection port,

the first material and the third material are unable to be integrally bonded,

the rigidizer arms are joined to the frame separately from one another,

the frame includes a channel portion and the seal-forming structure includes a tongue portion configured to be inserted into the channel portion when the seal-forming structure is removably connected to the frame,

the frame is symmetric across a first plane,

each of the rigidizer arms comprises a first curve such that a first portion of each of the rigidizer arms extends away from the first plane at the first curve,

each of the rigidizer arms comprises a second portion that extends from the first portion, the second portion having a second curve such that a surface of the second portion that faces the first plane is concave and configured to be positioned against a corresponding one of the patient's cheeks in use,

the second portion of each of the rigidizer arms is upwardly curved such that in use a corresponding one of the length-adjustable side strap portions is directed between corresponding ones of the patient's eyes and ears,

the textile material is elastically stretchable,

the length-adjustable side strap portions are dimensioned such that the length-adjustable top strap portion and the back strap portion and the gap are positioned posterior to the patient's ears in use,

the length-adjustable side strap portions, the length-adjustable top strap portion, and the back strap portion are dimensioned such that the length-adjustable top strap portion and the back strap portion split from one another at a location superior to the patient's ears in use,

the length-adjustable top strap portion is configured to engage the patient's head across the parietal bones in use and the back strap portion is configured to engage the patient's head proximal to the occipital bone in use,

each of the rigidizer arms comprises an enclosable section, the frame being overmoulded around the enclosable section of each of the rigidizer arms,

each of the rigidizer arms comprises a main body portion and an extension portion that extends from the main body portion and is joined to the frame,

the extension portion is narrower than the main body portion,

each of the length-adjustable side strap portions comprises a sleeve portion, each of the rigidizer arms extending into the sleeve portion of a corresponding one of the length-adjustable side strap portions,

the textile material is flexible such that a distance between the length-adjustable top strap portion and the back strap portion is adjustable in use,

the second material is silicone,

the seal-forming structure further comprises a base that is removably connected to the frame,

the frame includes a rim that extends away from the frame in a direction opposite the connection port, the rim forming an opening,

an inner periphery of the base is configured to surround and seal against an outer periphery of the rim when the base is removably connected to the frame, and

the tube comprises a swivel connector positioned on an end of the tube opposite the frame.

31 . The patient interface of claim 30 , wherein:

a pair of mesh portions are positioned on the frame on a corresponding lateral side of the connection port, and the first group of vent holes and the second group of vent holes being formed through corresponding ones of the mesh portions,

the seal-forming structure comprises nasal pillows configured to contact and seal against the underside of the patient's nose at corresponding ones of the patient's nares,

the base and the frame are structured to be removably connected with an audible snap fit, and

a visual indicator is formed on an exterior surface of the seal-forming structure to indicate orientation of the seal-forming structure for assembly to the frame.

32 . The patient interface of claim 30 , wherein:

the seal-forming structure comprises a nasal cradle, and

the base is constructed from silicone having a higher durometer than silicone of the remainder of the seal-forming structure.

33 . The patient interface of claim 1 , wherein:

the tube is permanently connected to the frame at the connection port,

the seal-forming structure comprises nasal pillows configured to contact and seal against the underside of the patient's nose at corresponding ones of the patient's nares,

the rigidizer arms are joined to the frame separately from one another,

the frame is symmetric across a first plane,

each of the rigidizer arms comprises a first curve such that a first portion of each of the rigidizer arms extends away from the first plane at the first curve,

each of the rigidizer arms comprises a second portion that extends from the first portion, the second portion having a second curve such that a surface of the second portion that faces the first plane is concave and configured to be positioned against a corresponding one of the patient's cheeks in use,

the second portion of each of the rigidizer arms is upwardly curved such that in use a corresponding one of the length-adjustable side strap portions is directed between corresponding ones of the patient's eyes and ears,

the length-adjustable side strap portions, the length-adjustable top strap portion, and the back strap portion are dimensioned such that the length-adjustable top strap portion and the back strap portion split from one another at a location superior to the patient's ears in use,

the length-adjustable top strap portion is configured to engage the patient's head across the parietal bones in use and the back strap portion is configured to engage the patient's head proximal to the occipital bone in use,

each of the rigidizer arms comprises a main body portion and an extension portion that extends from the main body portion and is joined to the frame,

the extension portion is narrower than the main body portion,

the textile material is flexible such that a distance between the length-adjustable top strap portion and the back strap portion is adjustable in use,

the second material is silicone,

the tube comprises a swivel connector positioned on an end of the tube opposite the frame, and

a visual indicator is formed on an exterior surface of the seal-forming structure to indicate orientation of the seal-forming structure for assembly to the frame.

34 . The patient interface of claim 1 , wherein:

the tube is permanently connected to the frame at the connection port,

the seal-forming structure comprises a nasal cradle,

the seal-forming structure comprises a single orifice configured to direct the flow of air into both of the patient's nares during use,

the rigidizer arms are joined to the frame separately from one another,

the frame is symmetric across a first plane,

each of the rigidizer arms comprises a first curve such that a first portion of each of the rigidizer arms extends away from the first plane at the first curve,

each of the rigidizer arms comprises a second portion that extends from the first portion, the second portion having a second curve such that a surface of the second portion that faces the first plane is concave and configured to be positioned against a corresponding one of the patient's cheeks in use,

the second portion of each of the rigidizer arms is upwardly curved such that in use a corresponding one of the length-adjustable side strap portions is directed between corresponding ones of the patient's eyes and ears,

the length-adjustable side strap portions, the length-adjustable top strap portion, and the back strap portion are dimensioned such that the length-adjustable top strap portion and the back strap portion split from one another at a location superior to the patient's ears in use,

the length-adjustable top strap portion is configured to engage the patient's head across the parietal bones in use and the back strap portion is configured to engage the patient's head proximal to the occipital bone in use,

each of the rigidizer arms comprises a main body portion and an extension portion that extends from the main body portion and is joined to the frame,

the extension portion is narrower than the main body portion,

the textile material is flexible such that a distance between the length-adjustable top strap portion and the back strap portion is adjustable in use,

the second material is silicone,

the tube comprises a swivel connector positioned on an end of the tube opposite the frame, and

a visual indicator is formed on an exterior surface of the seal-forming structure to indicate orientation of the seal-forming structure for assembly to the frame.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: JOURDAN, RALPH
To: SCHAUENBURG HOSE TECHNOLOGY GMBH
Reel/Frame 062038/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: SCHAUENBURG HOSE TECHNOLOGY GMBH
To: GLOBALMED INC.
Reel/Frame 062038/0266 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: FORRESTER, MARTIN
To: GLOBALMED INC.
Reel/Frame 062038/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: GLOBALMED INC.
To: RESMED LIMITED
Reel/Frame 062038/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: WELLS, ALICIA KRISTIANNE; EDWARDS, CRAIG DAVID; SHANMUGA SUNDARA, SHIVA KUMAR; LEE, MURRAY WILLIAM; HASKARD, KIRRILY MICHELE; BARBARA, ANTHONY PAUL; WAGNER, STEWART JOSEPH; MAY, FREDERICK ARLET; GOLDSPINK, LACHLAN RICHARD; TAN, CHIA IK
To: RESMED LIMITED
Reel/Frame 062104/0566 →
CHANGE OF NAME Recorded Dec 9, 2022
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 062104/0584 →
Priority Claims (8)
AU 2012903504 · Aug 15, 2012 · national
AU 2012904378 · Oct 8, 2012 · national
AU 2013900132 · Jan 16, 2013 · national
AU 2013900133 · Jan 16, 2013 · national
NZ 605907 · Jan 16, 2013 · national
NZ 605908 · Jan 16, 2013 · national
AU 2013900168 · Jan 18, 2013 · national
AU 2013902305 · Jun 24, 2013 · national
Continuity (11)
Continuation 17727103 · Apr 22, 2022
Continuation 17672784 · Feb 16, 2022
Continuation 16552310 · Aug 27, 2019
Continuation 15859817 · Jan 2, 2018
Continuation 14417610
Provisional Application 61839916 · Jun 27, 2013
Provisional Application 61837521 · Jun 20, 2013
Provisional Application 61823192 · May 14, 2013
Provisional Application 61817674 · Apr 30, 2013
Provisional Application 61676456 · Jul 27, 2012
Related Publication 20230106307A1 · Apr 6, 2023
References Cited (287)
US 2931356A · Hermann · 1960 [cited by applicant]
US 4686354A · Makin · 1987 [cited by applicant]
US 4782832A · Trimble et al. · 1988 [cited by applicant]
US 4944310A · Sullivan · 1990 [cited by applicant]
US 5181507A · Michel et al. · 1993 [cited by applicant]
US 5243971A · Sullivan · 1993 [cited by applicant]
US 5357948A · Eilentropp · 1994 [cited by applicant]
US 5438979A · Johnson, Jr. et al. · 1995 [cited by applicant]
US 5459910A · Anscher · 1995 [cited by applicant]
US 5704345A · D'Souza · 1998 [cited by applicant]
US 5724965A · Handke · 1998 [cited by applicant]
US 6119694A · Correa · 2000 [cited by examiner]
US 6152186A · Arney et al. · 2000 [cited by applicant]
US 6293900B1 · Bove et al. · 2001 [cited by applicant]
US D450833S · Olivieri · 2001 [cited by applicant]
US 6402712B1 · Gaurvy · 2002 [cited by applicant]
US 6418929B1 · Norfleet · 2002 [cited by applicant]
US 6513526B2 · Kwok · 2003 [cited by applicant]
US 6532959B1 · Berthon-Jones · 2003 [cited by applicant]
US 6581594B1 · Drew et al. · 2003 [cited by applicant]
US 6631718B1 · Lovell · 2003 [cited by applicant]
US D483548S · Chambers · 2003 [cited by applicant]
US 6820615B1 · Feng · 2004 [cited by applicant]
US 6823869B2 · Raje et al. · 2004 [cited by applicant]
US 7210481B1 · Lovell et al. · 2007 [cited by applicant]
US 7219669B1 · Lovell et al. · 2007 [cited by applicant]
US 7296575B1 · Radney · 2007 [cited by applicant]
US 7370652B2 · Matula, Jr. · 2008 [cited by examiner]
US 7562658B2 · Madaus et al. · 2009 [cited by applicant]
US 7743767B2 · Ging et al. · 2010 [cited by applicant]
US 7856982B2 · Matula, Jr. · 2010 [cited by applicant]
US 7866944B2 · Kenyon et al. · 2011 [cited by applicant]
US 8136525B2 · Lubke et al. · 2012 [cited by applicant]
US 8636479B2 · Kenyon et al. · 2014 [cited by applicant]
US 8638014B2 · Sears et al. · 2014 [cited by applicant]
US 8851074B2 · Chien · 2014 [cited by applicant]
US 9265909B2 · Ho et al. · 2016 [cited by applicant]
US 9302065B2 · Smith · 2016 [cited by applicant]
US 9387302B2 · Dravitzki et al. · 2016 [cited by applicant]
US 9561339B2 · Mcauley · 2017 [cited by applicant]
US 9844639B2 · Ho · 2017 [cited by applicant]
US 9889267B2 · Wells et al. · 2018 [cited by applicant]
US 10080856B2 · Mclaren · 2018 [cited by applicant]
US 10252015B2 · Mcauley · 2019 [cited by applicant]
US 10384029B2 · Mcauley · 2019 [cited by applicant]
US 10543332B2 · Scheiner · 2020 [cited by applicant]
US 10912909B2 · Wells et al. · 2021 [cited by applicant]
US 11253668B2 · Freestone · 2022 [cited by applicant]
US 11260194B2 · Mcauley · 2022 [cited by applicant]
US 11291790B2 · Mcauley · 2022 [cited by applicant]
US 11491294B2 · Wells et al. · 2022 [cited by applicant]
US 11565068B2 · Wells et al. · 2023 [cited by applicant]
US 11583651B2 · Wells et al. · 2023 [cited by applicant]
US 20020053347A1 · Ziaee · 2002 [cited by applicant]
US 20020195107A1 · Smaldone · 2002 [cited by applicant]
US 20030075180A1 · Raje et al. · 2003 [cited by applicant]
US 20030196655A1 · Ging et al. · 2003 [cited by applicant]
US 20030196656A1 · Moore et al. · 2003 [cited by applicant]
US 20040149280A1 · Semeniuk · 2004 [cited by applicant]
US 20040182398A1 · Sprinkle et al. · 2004 [cited by applicant]
US 20040221850A1 · Ging · 2004 [cited by applicant]
US 20050011521A1 · Sprinkle et al. · 2005 [cited by applicant]
US 20050011524A1 · Thomlinson · 2005 [cited by applicant]
US 20050109343A1 · Flannigan et al. · 2005 [cited by applicant]
US 20050155604A1 · Ging et al. · 2005 [cited by applicant]
US 20050199242A1 · Matula · 2005 [cited by applicant]
US 20050228822A1 · Wason · 2005 [cited by applicant]
US 20050241644A1 · Gunaratnam · 2005 [cited by applicant]
US 20060042629A1 · Geist · 2006 [cited by applicant]
US 20060060200A1 · Ho et al. · 2006 [cited by applicant]
US 20060081256A1 · Palmer · 2006 [cited by applicant]
US 20060096598A1 · Ho et al. · 2006 [cited by applicant]
US 20060124131A1 · Chandran · 2006 [cited by applicant]
US 20060169004A1 · Belluye et al. · 2006 [cited by applicant]
US 20060237017A1 · Davidson · 2006 [cited by examiner]
US 20060283461A1 · Lubke · 2006 [cited by applicant]
US 20070072249A1 · Baum et al. · 2007 [cited by applicant]
US 20070079486A1 · Paik · 2007 [cited by applicant]
US 20070209663A1 · Marque · 2007 [cited by applicant]
US 20080264413A1 · Doherty et al. · 2008 [cited by applicant]
US 20090032026A1 · Guney · 2009 [cited by applicant]
US 20090044808A1 · Guney · 2009 [cited by examiner]
US 20090050156A1 · Ng et al. · 2009 [cited by applicant]
US 20090078259A1 · Kooij et al. · 2009 [cited by applicant]
US 20090107508A1 · Brambilla · 2009 [cited by examiner]
US 20090126739A1 · Ng · 2009 [cited by applicant]
US 20090223521A1 · Howard et al. · 2009 [cited by applicant]
US 20090250065A1 · Omura et al. · 2009 [cited by applicant]
US 20090277525A1 · Jourdan · 2009 [cited by applicant]
US 20100000534A1 · Kooij et al. · 2010 [cited by applicant]
US 20100000543A1 · Berthon-Jones et al. · 2010 [cited by applicant]
US 20100108072A1 · D'Souza · 2010 [cited by applicant]
US 20100192954A1 · Sullivan · 2010 [cited by applicant]
US 20100224276A1 · Forrester et al. · 2010 [cited by applicant]
US 20100229868A1 · Rummery · 2010 [cited by applicant]
US 20100258136A1 · Doherty · 2010 [cited by applicant]
US 20100313891A1 · Veliss · 2010 [cited by applicant]
US 20110023874A1 · Bath et al. · 2011 [cited by applicant]
US 20110056497A1 · Scheiner · 2011 [cited by applicant]
US 20110067704A1 · Kooij · 2011 [cited by applicant]
US 20110088699A1 · Skipper · 2011 [cited by applicant]
US 20110146685A1 · Allan · 2011 [cited by applicant]
US 20110155140A1 · Ho · 2011 [cited by applicant]
US 20110232649A1 · Collazo · 2011 [cited by applicant]
US 20110247619A1 · Formica et al. · 2011 [cited by applicant]
US 20110265796A1 · Amarasinghe · 2011 [cited by applicant]
US 20120028542A1 · Weerawansa · 2012 [cited by applicant]
US 20120138063A1 · Eves et al. · 2012 [cited by applicant]
US 20120204878A1 · Smith · 2012 [cited by examiner]
US 20120204879A1 · Cariola et al. · 2012 [cited by applicant]
US 20120222680A1 · Eves · 2012 [cited by applicant]
US 20120234326A1 · Mazzone et al. · 2012 [cited by applicant]
US 20120304999A1 · Swift · 2012 [cited by applicant]
US 20120318270A1 · Mcauley et al. · 2012 [cited by applicant]
US 20130074845A1 · Smith et al. · 2013 [cited by applicant]
US 20130133659A1 · Ng et al. · 2013 [cited by applicant]
US 20130133660A1 · Ng et al. · 2013 [cited by applicant]
US 20130213400A1 · Barlow et al. · 2013 [cited by applicant]
US 20140026890A1 · Haskard et al. · 2014 [cited by applicant]
US 20150217074A1 · Wells et al. · 2015 [cited by applicant]
US 20150352306A1 · Scheiner · 2015 [cited by applicant]
US 20160144146A1 · Huddart · 2016 [cited by applicant]
US 20170119988A1 · Allan · 2017 [cited by applicant]
US 20180140795A1 · Wells et al. · 2018 [cited by applicant]
US 20180256844A1 · Galgali · 2018 [cited by applicant]
US 20200009345A1 · Wells et al. · 2020 [cited by applicant]
US 20220241538A1 · Wells et al. · 2022 [cited by applicant]
AU 2010256351B2 · 2010 [cited by applicant]
CN 201166209Y · 2008 [cited by applicant]
CN 101380497A · 2009 [cited by applicant]
CN 101455871A · 2009 [cited by applicant]
CN 101523104A · 2009 [cited by applicant]
CN 101951984A · 2011 [cited by applicant]
CN 101969871A · 2011 [cited by applicant]
CN 102014999A · 2011 [cited by applicant]
CN 202100847U · 2012 [cited by applicant]
CN 202152891U · 2012 [cited by applicant]
CN 102458548A · 2012 [cited by applicant]
EP 0014217A1 · 1980 [cited by applicant]
EP 0747078A2 · 1996 [cited by applicant]
EP 1356841 · 2003 [cited by applicant]
EP 2027880 · 2009 [cited by applicant]
EP 2022528 · 2009 [cited by applicant]
EP 2042209A1 · 2009 [cited by applicant]
EP 2140902 · 2010 [cited by applicant]
GB 2173274A · 1986 [cited by applicant]
JP 54172317 · 1979 [cited by applicant]
JP 61232864 · 1986 [cited by applicant]
JP 2007285515 · 2007 [cited by applicant]
JP 200939528 · 2009 [cited by applicant]
JP 2009072596 · 2009 [cited by applicant]
JP 2011500229 · 2011 [cited by applicant]
JP 2012513231A · 2012 [cited by applicant]
JP 2012526592 · 2012 [cited by applicant]
JP 2012527908A · 2012 [cited by applicant]
NZ 539836 · 2007 [cited by applicant]
NZ 553756 · 2007 [cited by applicant]
NZ 553822 · 2007 [cited by applicant]
NZ 553824 · 2007 [cited by applicant]
NZ 553825 · 2007 [cited by applicant]
NZ 562418 · 2007 [cited by applicant]
NZ 562419 · 2007 [cited by applicant]
NZ 550675 · 2008 [cited by applicant]
RU 2214295C1 · 2002 [cited by applicant]
RU 2379075C2 · 2008 [cited by applicant]
WO WO1998004310 · 1998 [cited by applicant]
WO WO1998034665 · 1998 [cited by applicant]
WO 9904842 · 1999 [cited by applicant]
WO WO0069521 · 2000 [cited by applicant]
WO WO2000078381 · 2000 [cited by applicant]
WO WO0197892 · 2001 [cited by applicant]
WO WO2002011804 · 2002 [cited by applicant]
WO WO2002047749 · 2002 [cited by applicant]
WO WO03090827 · 2003 [cited by applicant]
WO WO2004022147 · 2004 [cited by applicant]
WO WO2004041342 · 2004 [cited by applicant]
WO WO2004073778 · 2004 [cited by applicant]
WO WO2005063328 · 2005 [cited by applicant]
WO WO2005079726A1 · 2005 [cited by applicant]
WO WO2006069415 · 2006 [cited by applicant]
WO WO2006074513 · 2006 [cited by applicant]
WO WO2006130903 · 2006 [cited by applicant]
WO WO2007012140 · 2007 [cited by applicant]
WO WO2007022562 · 2007 [cited by applicant]
WO WO2007041751 · 2007 [cited by applicant]
WO WO2007041786 · 2007 [cited by applicant]
WO WO2007133332A2 · 2007 [cited by applicant]
WO WO2008007985 · 2008 [cited by applicant]
WO WO2008011682 · 2008 [cited by applicant]
WO WO2008011683 · 2008 [cited by applicant]
WO WO2009022250A2 · 2009 [cited by applicant]
WO WO2009052560 · 2009 [cited by applicant]
WO WO2010073142 · 2010 [cited by applicant]
WO WO2010131189A1 · 2010 [cited by applicant]
WO 2010139014A1 · 2010 [cited by applicant]
WO WO2010135785 · 2010 [cited by applicant]
WO WO2011022751 · 2011 [cited by applicant]
WO WO2011048510 · 2011 [cited by applicant]
WO WO2011048519 · 2011 [cited by applicant]
WO 2011051837 · 2011 [cited by applicant]
WO 2011060479 · 2011 [cited by applicant]
WO 2011060479A1 · 2011 [cited by applicant]
WO WO2011110961 · 2011 [cited by applicant]
WO WO2011121466 · 2011 [cited by applicant]
WO WO2011142678 · 2011 [cited by applicant]
WO 2012028995A1 · 2012 [cited by applicant]
WO 2012040791 · 2012 [cited by applicant]
WO 2012045127 · 2012 [cited by applicant]
WO WO2012040792A1 · 2012 [cited by applicant]
WO WO2012047121A1 · 2012 [cited by applicant]
WO WO2012171072 · 2012 [cited by applicant]
WO 2013003477A1 · 2013 [cited by applicant]
WO 2013026092A1 · 2013 [cited by applicant]
WO WO2013026091 · 2013 [cited by applicant]
WO WO2013020167 · 2013 [cited by applicant]
WO 2013042003 · 2013 [cited by applicant]
WO WO2013057647 · 2013 [cited by applicant]
WO WO2014015382A1 · 2014 [cited by applicant]
WO 2014025267A1 · 2014 [cited by applicant]
WO WO2014077708A1 · 2014 [cited by applicant]
WO 2014142681 · 2014 [cited by applicant]
Office Action dated Mar. 22, 2023 issued in Chinese Application No. 202010139439.8 with English translation (16 pages). [cited by applicant]
Office Action dated Oct. 9, 2022 issued in Chinese Application No. 202010139439.8 with English translation (19 pages). [cited by applicant]
Office Action dated Oct. 31, 2022 issued in Japanese Application No. 2021-133424 with English translation (10 pages). [cited by applicant]
Notice of Allowance dated Jul. 19, 2021 issued in Japanese Application No. 2020-030604 (3 pages). [cited by applicant]
Office Action dated May 7, 2019 issued in Japanese Application No. 2018-107698 with English translation (13 Pages). [cited by applicant]
Notice of Allowance dated Jan. 27, 2020 issued in Japanese Application No. 2018-1076925 (3 Pages). [cited by applicant]
Extended European Search Report dated Aug. 23, 2019 issued in European Application No. 18215569.7 (17 pages). [cited by applicant]
Office Action dated Mar. 31, 2022 issued in U.S. Appl. No. 16/552,310 (24 pages). [cited by applicant]
Further Examination Report issued in New Zealand Application No. 724289 dated Nov. 16, 2018, (2 pages). [cited by applicant]
First Office Action issued in Chinese Application No. 201380050915.7 dated Nov. 30, 2018, with English translation, (14 pages). [cited by applicant]
Notice of Opposition issued in New Zealand Application No. 728967 dated Dec. 21, 2018, (2 pages). [cited by applicant]
Further Examination Report issued in New Zealand Application No. 724289 dated Jun. 20, 2018, (2 Pages). [cited by applicant]
First Examination Report issued in New Zealand Application No. 744244 dated Aug. 6, 2018, (4 pages). [cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 14/760,808, dated Aug. 16, 2018, (16 Pages). [cited by applicant]
Pre-Appeal Examination Report issued in related Japanese Application No. JP 2015-523344, dated Sep. 10, 2018, with English translation (9 pages). [cited by applicant]
Cover Letter for SE Adverse Report and Examiner's Report to the Registrar issued in Malaysian Application No. PI201570023, dated Sep. 28, 2018 (3 pages). [cited by applicant]
First Office Action issued in related Taiwanese Application No. 106116271 dated Jul. 10, 2018, with English translation, (21 pages). [cited by applicant]
Office Action dated Apr. 2, 2022 issued in Chinese Application No. 202010139439.8 with English translation (19 pages). [cited by applicant]
Second Office Action issued in related Japanese Application No. 2015-552955 with English Translation, dated Apr. 9, 2018, 5 pages. [cited by applicant]
Communication pursuant to Article 94(3) EPC issued in European Application No. 14 740 791.0, dated Feb. 16, 2018, 9 pages. [cited by applicant]
Decision of Rejection issued in related Japanese Application No. 2015-523344 with English Translation, dated Feb. 5, 2018, 8 pages. [cited by applicant]
First Office Action issued in Taiwan Application No. 103101682 with English translation, dated Jul. 27, 2017, (17 pages). [cited by applicant]
Second Office Action issued in Chinese Application No. 201480019556.3 with English translation, dated Jul. 12, 2017, (18 pages). [cited by applicant]
European Search Report issued in European Application No. 14862678.1, dated May 3, 2017, (16 Pages). [cited by applicant]
International Search Report of PCT/AU2013/000830 mailed Nov. 22, 2013, 26 pages. [cited by applicant]
Written Opinion of the ISA for PCT/AU2013/000830 mailed Nov. 22, 2013, 26 pages. [cited by applicant]
Written Opinion of the ISA for PCT/AU2013/000830 mailed Sep. 9, 2014, 16 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/AU2013/000830 dated Nov. 25, 2014, 259 Pages. [cited by applicant]
First Examination Report issued in related New Zealand Application No. 724289, dated Apr. 19, 2017, (2 pages). [cited by applicant]
First Office Action issued in related Japanese Application No. 2015-523344 with English translation, dated May 29, 2017, (13 pages). [cited by applicant]
Office Action issued in related Russian Application No. 2015105510 with English translation, dated Jun. 1, 2017, (7 pages). [cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 13/952,165 dated Mar. 29, 2017, 51 pages. [cited by applicant]
Office Action issued in related Russian Application No. 2015105510 with English translation, dated Mar. 24, 2017, (9 pages). [cited by applicant]
Office Action issued in related Russian Application No. 2015105510 dated Mar. 22, 2016, (2 pages). [cited by applicant]
Written Opinion issued in related Singagore Application No. 11201500606U dated Oct. 23, 2015, (7 pages). [cited by applicant]
Supplementary European Search Report issued in related European Application No. 13822087.6, dated Feb. 24, 2016 (15 pages). [cited by applicant]
Third Office Action issued in Chinese Application No. 201480019556.3 with English Translation, dated Jan. 24, 2018, 18 pages. [cited by applicant]
Patent Examination Report No. 1 issued in related Australian Application No. 2015264928 dated Jul. 6, 2016, 3 pages. [cited by applicant]
Second Written Opinion issued in related Singaporean Application No. 1120500606U dated Dec. 8, 2016, 6 pages. [cited by applicant]
Examination Report issued in related European Application No. 13 822 087.6 dated Feb. 23, 2017, 7 pages. [cited by applicant]
Patent Examination Report No. 1 issued in related Australian Application No. 2013296145 dated Oct. 2, 2015, 5 pages. [cited by applicant]
Office Action (Non-Final) issued in U.S. Appl. No. 13/952,165, dated Feb. 24, 2016, 47 pages. [cited by applicant]
Final Office Action issued in U.S. Appl No. 13/952,165, dated Aug. 3, 2016, 22 pages. [cited by applicant]
First Examination Report issued in related New Zealand Application No. 605907, dated Jan. 22, 2013, 2 Pages. [cited by applicant]
Further Examination Report Postponed Acceptance issued in related New Zealand Application No. 605907, dated Apr. 4, 2013, 1 page. [cited by applicant]
First Examination Report issued in related New Zealand Application No. 605908, dated Jan. 18, 2013, 1 page. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 605908, dated Jan. 28, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 605908, dated Apr. 4, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 605908, dated Jul. 4, 2013, 1 pages. [cited by applicant]
First Examination Report issued in related New Zealand Application No. 610823, dated May 23, 2013, 3 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 610823, dated Jul. 11, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 610823, dated Aug. 23, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 610823, dated Jul. 26, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 610823, dated Nov. 14, 2013, 2 pages. [cited by applicant]
Further Examination Report issued in related New Zealand Application No. 610823, dated Dec. 19, 2013, 2 pages. [cited by applicant]
“Respirator Physiology”, by John B. West, Lippincott Williams & Wilkins, 9th edition published 2011 (8 pages). [cited by applicant]
Patent Examination Report No. 2 issued in related Australian Application No. 2013296145 dated Nov. 26, 2015, 3 pages. [cited by applicant]
First Office Action issued in related Japanese Application No. 2015-552955 with English translation, dated Nov. 2, 2017, 10 pages. [cited by applicant]
Notification of the First Office Action dated Apr. 2, 2022 issued in Chinese Application No. 2020101394398 with Enlish translation (19 pages). [cited by applicant]
Office Action dated Jun. 6, 2022 issued in Japanese Application No. 2021-133424 with English translation (11 pages). [cited by applicant]
Further Examination Report dated Jul. 13, 2022 issued in New Zealand Application No. 774983 (1 page). [cited by applicant]
Notice of Allowance dated Jul. 7, 2022 issued in U.S. Appl. No. 17/672,784 (21 pages). [cited by applicant]
Notice of Allowance mailed Apr. 22, 2024 issued in Japanese Application No. 2023-060821 (3 pages). [cited by applicant]
Further Examination Report dated May 30, 2023 issued in New Zealand Application No. 792996 (2 pages). [cited by applicant]
Extended European Search Report dated Aug. 1, 2023 issued in European Application No. 23165557.2 (22 pages). [cited by applicant]
Office Action dated Jul. 29, 2025 issued in Chinese Application No. 202310489415.9 with English translation (15 pages). [cited by applicant]